Wechselwirkungen · Clopidogrel HCS
Clopidogrel HCS 75 mg film-coated tablets · Abschnitt 4.5 · PDF-Seite 6–7
HOS-124941 · Präparat HOS-095961
6 Apart from the specific medicinal product interaction information described above, interaction studies with clopidogrel and some medicinal products commonly administered in patients with atherothrombotic disease have not been performed. However, patients entered into clinical trials with clopidogrel received a variety of concomitant medicinal products including diuretics, beta blockers, ACEI, calcium antagonists, cholesterol lowering agents, coronary vasodilators, antidiabetic agents (including insulin), antiepileptic agents, and GPIIb/IIIa antagonists without evidence of clinically significant adverse interactions.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
RxNorm-Namen im Text (wörtliche Treffer, Rolle nicht bewertet): calcium (HOS-085615) clopidogrel (HOS-087927) cholesterol (HOS-087961)
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2018-08-01T02:00:00Z · SHA-256 ca426beb29f75b624527d51329ba517d85960904d2b54fe0bb1e1592d0525e34 · Passage 1d249e6eb5bdfa8381da5bf7df6e4291a052ebacfdeb33c10aac7e1ec6ab696f · Zeichen 6629–7255 im Abschnitt